Acorafloxacin HCl
Code | Size | Price |
---|
TAR-T23622-5mg | 5mg | £1,171.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T23622-50mg | 50mg | £2,303.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T23622-100mg | 100mg | £3,042.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Acorafloxacin is a broad-spectrum fluoroquinolone antibacterial drug being developed for the treatment of acute bacterial skin and skin structure infections and community-acquired pneumonia.
CAS:
1001162-01-1
Formula:
C21H24ClF2N3O4
Molecular Weight:
455.89
Purity:
0.98
SMILES:
Cl.COc1c(N2CCCC(C2)=C(/F)CN)c(F)cc2c1n(cc(C(O)=O)c2=O)C1CC1
References
1. Mattes TA, Escalante-Semerena JC. Facile isolation of ?-ribazole from vitamin B(12) hydrolysates using boronate affinity chromatography. J Chromatogr B Analyt Technol Biomed Life Sci. 2018 May 16;1090:52-55. doi: 10.1016/j.jchromb.2018.05.022. [Epub ahead of print] PubMed PMID: 29783174.
2. Rudnicki K, Poltorak L, Skrzypek S, Sudholter EJR. Fused silica micro-capillaries used for a simple miniaturization of the electrified liquid - liquid interface. Anal Chem. 2018 May 21. doi: 10.1021/acs.analchem.8b01351. [Epub ahead of print] PubMed PMID: 29781599.
3. Cao XY, Kong FZ, Zhang Q, Liu WW, Liu XP, Li GQ, Zhong R, Fan LY, Xiao H, Cao CX. iPhone-imaged and cell-powered electrophoresis titration chip for the alkaline phosphatase assay in serum by the moving reaction boundary. Lab Chip. 2018 May 21. doi: 10.1039/c8lc00163d. [Epub ahead of print] PubMed PMID: 29780999.
4. Isaacson SH, Fahn S, Pahwa R, Tanner CM, Espay AJ, Trenkwalder C, Adler CH, Patni R, Johnson R. Parkinson's Patients with Dyskinesia Switched from Immediate Release Amantadine to Open-label ADS-5102. Mov Disord Clin Pract. 2018 Mar-Apr;5(2):183-190. doi: 10.1002/mdc3.12595. Epub 2018 Feb 23. PubMed PMID: 29780852; PubMed Central PMCID: PMC5947645.